Back to Search
MARK AGULNIK MD
MD
Medical Oncology Physician
NPI: 1164448734IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
036-118071(IL)C170270(CA)
Education
OTHER
Class of 1998
Research & Publications (20)
Nasopharyngeal carcinoma: current management, future directions and dental implications.
PMID 18061518·Oral Oncol·2008
6-review
Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
PMID 17761983·J Clin Oncol·2007
3-trial
Malignancies of the head and neck: the role for molecular targeted agents.
PMID 17227235·Expert Opin Ther Targets·2007
6-review
Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib.
PMID 17538163·J Clin Oncol·2007
3-trial
Multidisciplinary Symposium on Head and Neck Cancer. 2 December 2005, Philadelphia, PA, USA.
PMID 16503821·Expert Opin Pharmacother·2006
8-other
Recent advances in the treatment of oligodendrogliomas.
PMID 16635430·Curr Neurol Neurosci Rep·2006
6-review
Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents.
PMID 17050865·J Clin Oncol·2006
8-other
The changing management of low-grade astrocytomas and oligodendrogliomas.
PMID 17113461·Hematol Oncol Clin North Am·2006
8-other
State-of-the-art management of nasopharyngeal carcinoma: current and future directions.
PMID 15756250·Br J Cancer·2005
6-review
Paclitaxel, carboplatin, and concomitant radiotherapy for resected patients with high risk head and neck cancer.
PMID 15920912·J Chemother·2005
3-trial
An update on the systemic therapy of malignant salivary gland cancers: role of chemotherapy and molecular targeted agents.
PMID 15579019·Curr Med Chem Anticancer Agents·2004
6-review
Malignant lymphoma of mucosa-associated lymphoid tissue of the lacrimal gland: case report and review of literature.
PMID 11232953·Am J Clin Oncol·2001
5-case
Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib.
PMID 19309723·Head Neck·2009
3-trial
Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy.
PMID 19170238·Cancer·2009
8-other
Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.
PMID 18544445·Semin Oncol·2008
6-review
Promising newer molecular-targeted therapies in head and neck cancer.
PMID 18681486·Drugs·2008
8-other
The role of inhibitors of the epidermal growth factor in management of head and neck cancer.
PMID 18691458·J Natl Compr Canc Netw·2008
6-review
Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions.
PMID 18208368·Expert Opin Ther Targets·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1441 EASTLAKE AVE
LOS ANGELES, CA 90089 - Phone
- (323) 865-3000
Quick Facts
- NPI
- 1164448734
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile